ICARES Medicus, Inc. (6612.TWO)
Taipei Exchange · TWD · Healthcare · Medical Instruments & Supplies
NT$69.40 (+0.00%) as of
Key statistics
- Market cap
- 3.26B
- P/E (TTM)
- 38.77
- EPS (TTM)
- 1.79
- Dividend yield
- 0.44%
- 52-week range
- 59.96 – 83.03
- Beta
- 0.29
- Revenue (TTM)
- 1.21B
- Profit margin
- 7.73%
- Volume
- 11.20k
About ICARES Medicus, Inc.
ICARES Medicus, Inc., together with its subsidiaries, engages in the research, development, manufacturing, and sale of ophthalmic medical devices in Taiwan, the United States, United Kingdom, Japan, Spain, China, Germany, and internationally. The company is also involved in the manufacturing, sales, and service of intraocular lenses (IOLs) and its implantation systems for use in treating cataracts, myopia, farsightedness, presbyopia, or astigmatism, as well as related technical services. In addition, it offers artificial crystal products; and lubricious implantable and invasive high-end nanomedicine material. Further, the company engages in molding, mold design, and development; production of medical devices and electronic plastic products; and distribution of ophthalmic medical equipment. ICARES Medicus, Inc. was incorporated in 2011 and is based in Zhubei, Taiwan.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Headquarters
- Zhubei, Taiwan
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.